International Clinical Trial: Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast Cancer

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07825753) titled 'Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast Cancer' on Sept. 7.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Fudan University

Condition: Advanced or Metastatic Pancreatic Adenocarcinoma Advanced or Metastatic Breast Cancer (BC)

Intervention: Drug: Trastuzumab emtansine (T-DM1) Drug: Trastuzumab deruxtecan (T-DXd) Drug: Datopotamab deruxtecan (Dato-DXd) Drug: Sacituzumab govitecan (SG) Drug: Enfortumab vedotin (EV) Drug: Becotatug vedotin (MRG0...